Brief: Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial
05/09/2024 11:13
Sept 5 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA ANNOUNCES FIRST PARTICIPANT DOSED IN AUR200 SINGLE
ASCENDING DOSE TRIAL
* AURINIA PHARMACEUTICALS INC - DATA FROM AUR200 STUDY
EXPECTED IN
FIRST HALF OF 2025
Source text for Eikon: ID:nBw92C0Sqa
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death